arrow
M

Maryam Kavousi

Erasmus MC
H指数:84
被引数:5.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Risk prediction in patients with heart failure with preserved ejection fraction: the LIFE-Preserved model

射血分数保留的心力衰竭患者风险预测:LIFE-Preserved模型

2026-03-110
OA
Prediction of incident heart failure in established atherosclerotic cardiovascular disease: the SMART2-HF model

预测动脉粥样硬化性心血管疾病患者发生心衰的风险:SMART2-HF模型

2026-03-110
OA
Underuse of statins in MASLD despite population-based associations with lower liver stiffness

尽管与较低的肝脏硬度存在基于人群的关联,但MASLD中他汀类药物的使用不足

2026-02-110
OAAI
Anticoagulation Therapeutic Ranges and Clinical Outcomes in Patients with a Mechanical Heart Valve Treated with Vitamin K Antagonists-a Nationwide Linked-data Dutch Study

抗凝治疗范围与接受维生素K拮抗剂治疗的人工心脏瓣膜患者的临床结局——一项荷兰全国性关联数据研究

2026-01-010
OA
Sex differences in care for acute coronary syndrome in patients under 60 years: Primary care presentation, referral patterns, hospitalizations and clinical outcomes

急性冠状动脉综合征患者中,60岁以下患者的性别差异:初级保健表现、转诊模式、住院情况和临床结局

2025-12-170
OAAI
Association between carotid-femoral pulse wave velocity and cardiovascular disease in individuals with moderate blood pressure: a systematic review and individual participant meta-analysis

颈股动脉脉搏波速度与中度血压个体中心血管疾病之间的关联:一项系统综述和个体参与者meta分析

2025-12-120
OA
Sex differences in outcomes of vitamin K antagonist treatment in patients with a mechanical heart valve: a Dutch population-based cohort study

维生素K拮抗剂治疗在机械心脏瓣膜患者中的结局性别差异:一项荷兰基于人群的队列研究

2025-10-080
OAAI
Physical activity and mortality: towards healthspan-oriented metrics and outcomes. A Scientific Statement from the European Association of Preventive Cardiology (EAPC) of the ESC

身体活动与死亡率:迈向以健康寿命为导向的指标和结果。欧洲预防心脏病学协会(EAPC)的科学声明

2025-09-010
OAAI